Diagnosis of Postoperative Atrial Fibrillation by a Smartwatch

Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Oct 6, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how well smartwatches can help detect a condition called postoperative atrial fibrillation (POAF) in patients who have recently undergone heart surgery. POAF is a type of irregular heartbeat that can occur after surgery and can lead to serious health issues, including stroke and heart problems. The goal of the study is to see if smartwatches can accurately identify this condition within the first five days after patients leave the intensive care unit.

To be eligible for the trial, participants must be adults over 18 who have had heart surgery at Amiens University Hospital within the last four days. They should also be able to use the smartwatch to take a simple heart test. It's important to note that patients with a history of atrial fibrillation or those who need special heart monitoring cannot participate. If you decide to join, you will be using a smartwatch that checks your heart rhythm, which could help ensure you receive the right care after surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patient (\>18 years old)
• • The patient was hospitalized at Amiens University Hospital for on-pump cardiac surgery.
• • The patient has had a recent on-pump cardiac surgery (\< 96h)
• • Patient with the motor and cognitive abilities to perform a 1-lead ECG with the smartwatch
• • The patient was transferred to the cardiac surgery department of Amiens University Hospital.
• • The beneficiary of a social security plan
• • Signature of the consent to participate in the study
• Exclusion Criteria:
• • History of AF
• • Need for rhythmic monitoring by telemetry in cardiac intensive care for atrioventricular block and rapid supra and ventricular rhythm disorder (\>140 bpm).
• • An external pacemaker connected to epicardial electrodes depends on ventricular and atrial pacing.
• • Patients already included in an interventional clinical research protocol may alter the incidence of POAF.
• • Pregnant woman